Work

Hypomagnesaemia and its management following treatment with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs): Results from 3 randomized studies of necitumumab (NECI) plus chemotherapy in first-line treatment of patients with stage IV non-small cell lung cancer (NSCLC)

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw383.56

Authors: E. Vokes, M. Socinski, D.R. Spigel, L. Paz-Ares, R. Kurek, S. Nanda, G. Grau, J. Shahidi, N. Thatcher, D. Gandara

Institutions: University of Chicago, University of Chicago Medical Center, University of Pittsburgh, University of Pittsburgh Medical Center, Sarah Cannon, Hospital Universitario 12 De Octubre, Eli Lilly (Germany), Eli Lilly (United States), The Christie Hospital, The Christie NHS Foundation Trust, UC Davis Comprehensive Cancer Center, University of California, Davis

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2588550977

FWCI:

Cites:

Cited by:

Related to: 10